Emergency department opioid prescriptions are associated with small increases in hospital admission and subsequent opi ...

and willingness to continue opioid therapy. A literature search identified more than a dozen published reports on the use of pure opioid antagonists (naloxone, naltrexone, methylnaltrexone ...

New research reveals how CBD and THC interact with brain receptors, unlocking potential for safer cannabis-based treatments.

and new opioid agonist therapy prescriptions within 1 year. Secondary outcomes included all-cause acute care utilization and 7-day return ED visits for headache. Among patients who received (n ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

The Waterloo Region is facing an opioid crisis. According to Cameron Dearlove, the executive director at Porchlight ...

Antidotes are critical in toxicology, offering therapeutic solutions to poisoning by neutralizing toxins and enhancing the ...

HURA READ THE FULL HURA RESEARCH REPORT We are initiating coverage of TuHURA Biosciences, Inc. (NASDAQ:HURA) with a valuation ...

Cebranopadol reduced pain intensity in patients following abdominoplasty surgery in the ALLEVIATE-1 clinical trial.

Ben Hargreaves finds that a new line of attack could be the development of more effective non-opioid painkillers, with one potential therapy moving ... attaching to opioid receptors on nerve ...

The manufacturer of AV-101, an investigational, oral nonopioid, NMDA-targeting therapy to treat neuropathic pain, announced that it has received a U.S. patent for the treatment. AV-101 (4-Cl-KYN) is ...